Leng G C, Fowler B, Ernst E
Primary Care and Population Sciences, Royal Free and University College Medical School, Royal Free Campus, Rowland Hill Street, London, UK, NW3 2PF.
Cochrane Database Syst Rev. 2000(2):CD000990. doi: 10.1002/14651858.CD000990.
Exercise is an inexpensive, low risk option compared with other more invasive therapies for leg pain on walking (intermittent claudication).
The objective of this review was to determine the effects of exercise for leg pain.
The reviewers searched the Cochrane Peripheral Vascular Diseases Group trials register, Embase, reference lists of relevant articles, and contacted principal investigators of trials.
Randomised trials of exercise regimens in patients with leg pain on walking (intermittent claudication).
At least two reviewers extracted and assessed data trial quality independently. The reviewers contacted investigators to obtain information or data needed for the review that could not be found in published reports.
Fifteen trials were identified that met the inclusion criteria, but five were subsequently excluded because of poor quality. The remaining ten trials involved a total of almost 250 male and female patients with stable leg pain. The follow-up ranged from 12 weeks to 15 months. There was also some variation in the exercise regimens used, although all recommended at least two weekly sessions of, mostly, supervised exercise. All trials used a treadmill walking test as one of the outcome measures. The overall quality of the included trials was generally good, though the trials were all small (20-49 patients). Exercise therapy significantly improved maximal walking time (minutes) (weighted mean difference 6.51, 95% confidence interval 4.36 to 8.66, fixed effect model [FE]), with an overall improvement in walking ability of approximately 150% (range 74% to 230%). Exercise produced significant improvements in walking time compared with both angioplasty at six months (weighted mean difference 3.30, 95% confidence interval 2.21 to 4.39, FE) and antiplatelet therapy (weighted mean difference 1.06, 95% confidence interval 0.15 to 1.97, FE), and did not differ significantly from surgical treatment. In one small trial, exercise was less effective than pentoxifylline (weighted mean difference -0.45, 95% confidence interval -0.66 to -0.24, FE).
REVIEWER'S CONCLUSIONS: Exercise is of significant benefit to patients with leg pain.
与其他治疗行走时腿部疼痛(间歇性跛行)的侵入性更强的疗法相比,运动是一种成本低廉、风险较低的选择。
本综述的目的是确定运动对腿部疼痛的影响。
综述作者检索了Cochrane外周血管疾病组试验注册库、Embase、相关文章的参考文献列表,并联系了试验的主要研究者。
针对行走时腿部疼痛(间歇性跛行)患者的运动方案的随机试验。
至少两名综述作者独立提取并评估数据和试验质量。综述作者联系研究者以获取综述所需但在已发表报告中未找到的信息或数据。
确定了15项符合纳入标准的试验,但其中5项因质量差而随后被排除。其余10项试验共纳入了近250名患有稳定腿部疼痛的男性和女性患者。随访时间从12周至15个月不等。所采用的运动方案也存在一些差异,不过所有方案均建议每周至少进行两次运动,且大多为有监督的运动。所有试验均将跑步机行走试验作为结局指标之一。纳入试验的总体质量一般良好,不过这些试验规模都较小(20 - 49名患者)。运动疗法显著改善了最大行走时间(分钟)(加权平均差6.51,95%置信区间4.36至8.66,固定效应模型[FE]),行走能力总体提高了约150%(范围74%至230%)。与六个月时的血管成形术相比(加权平均差3.30,95%置信区间2.21至4.39,FE)以及抗血小板治疗相比(加权平均差1.06,95%置信区间0.15至1.97,FE),运动使行走时间有显著改善,且与手术治疗相比无显著差异。在一项小型试验中,运动的效果不如己酮可可碱(加权平均差 -0.45,95%置信区间 -0.66至 -0.24,FE)。
运动对腿部疼痛患者有显著益处。